Pediatric Sedation Management
Pediatric Sedation Management
Sean Barnes, MD, MBA,* Myron Yaster, MD,† Sapna R. Kudchadkar, MD‡
*Department of Anesthesiology & Critical Care Medicine, Johns Hopkins University School of Medicine, Charlotte R. Bloomberg Children’s
Center, Baltimore, MD.
†
Departments of Anesthesiology & Critical Care Medicine, Pediatrics, and Neurosurgery, Johns Hopkins University School of Medicine, Charlotte R. Bloomberg
Children’s Center, Baltimore, MD.
‡
Departments of Anesthesiology & Critical Care Medicine and Pediatrics, Johns Hopkins University School of Medicine, Charlotte R. Bloomberg Children’s
Center, Baltimore, MD.
Practice Gap
The differences between deep sedation and general anesthesia in the
practice of pediatric procedural sedation are often underemphasized and
must be a key part of clinician education to optimize patient selection and
safety.
Objectives After completing this article, the reader should be able to:
INTRODUCTION
AUTHOR DISCLOSURE Dr Barnes has Historically, children have been undertreated for pain and painful procedures.
disclosed no financial relationships relevant to Many practitioners believed that children neither remembered nor experienced
this article. Dr Yaster has disclosed that he has pain to the same degree that adults did. Fortunately, the past 25 years has seen an
received research support from the National
Institutes of Health (DA033390) and is a
explosion in research and interest in pediatric pain and sedation management.
consultant for the Data Safety Monitoring Indeed, the provision of sedation and analgesia for children undergoing proce-
Boards of Purdue Pharma and Endo dures and mechanical ventilation is now routine and the standard of care. Due to a
International. Dr Kudchadkar has disclosed
wide spectrum of ages and developmental levels, sedation of infants and children
that she was supported by the Johns Hopkins
CTSA Award Number 5KL2RR025006 from the is associated with unique challenges for even the most seasoned practitioner.
National Center for Advancing Translational Therefore, understanding the optimal level of sedation for each child’s circum-
Sciences of the National Institutes of Health.
stance and how to safely administer a given sedation plan is the focus of this
This commentary does contain discussion of
an unapproved/investigative use of a review. We discuss who provides this care, how patients should be assessed and
commercial product or device. prepared for sedation, the drugs and techniques used, and the surroundings in
Gastrointestinal System
Aspiration of gastric contents is a concern when performing
deep sedation. It is imperative to identify what and when the
patient last ate or drank, which is termed the NPO (nil per
os) time. The length of time a patient should be NPO before
Figure. Mallampati Scoring System used to predict ease of intubation. sedation depends on the type of solids or liquids ingested
• Class I: Full visibility of tonsils, uvula, and soft palate
• Class II: Visibility of hard and soft palate, upper portion of tonsils and (Table 2). (5) Even when patients fast, certain conditions
uvula increase the risk of aspiration during sedation, including
• Class III: Soft and hard palate and base of uvula are visible
• Class IV: Only hard palate is visible pregnancy, intraabdominal pathology (eg, bowel obstruc-
Chris Gralapp. tion, peritonitis), esophageal disease or history of previous
esophageal surgery, neuromuscular disease, altered mental
status, trauma, and morbid obesity. Pregnant women in the
increases the risk of bronchospasm. The respiratory exam- second or third trimester or any patient who has suffered
ination should include auscultation of the lungs to rule trauma (eg, motor vehicle collision, fall) are in the same risk
out any active wheezing or evidence of pneumonia, as stratification for aspiration as those who have just eaten. If a
demonstrated by crackles or rales. In addition, a reported procedure needs to be performed emergently, which is not
history of recent upper respiratory tract infection increases uncommon, these at-risk patients require rapid sequence
the risk of laryngospasm and bronchospasm as well as the induction and tracheal intubation to protect their airways.
need for supplemental oxygen. (4) Asking if a patient has
airway obstruction (snoring), mediastinal mass, or a history
of noisy breathing or has been formally diagnosed with TABLE 2. Fasting Recommendations for
obstructive or central sleep apnea is especially important. Sedation and Anesthesia
Patients who suffer from sleep-disordered breathing are at
FOOD TYPE MINIMUM FASTING PERIOD (HR)
increased risk of apnea and desaturation during sedation and
in the recovery period and should be considered for general Clear liquids 2
Codeine PO: 1.2 30–60 3–4 • Can cause severe No longer recommended in
nausea and vomiting pediatrics; 3%–5% of
• Histamine release population overmetabolize,
potentially leading to
catastrophic overdose.
Converted in liver to
morphine (10%). Newborns
and 10% of US population
cannot make this conversion.
Fentanyl IV: 0.001 1–2 0.5–1 • Pruritus Rarely causes cardiovascular
Transdermal: 0.001 12 2–3 • Bradycardia instability (relatively safer in
Transmucosal: 0.01 15 • Chest wall rigidity with hypovolemia, congenital heart
doses >5 mg/kg (but can disease, or head trauma).
occur at all doses); treat Respiratory depressant effect
with naloxone or much longer (4 hr) than
neuromuscular blockade analgesic effect. Levels of
unbound drug are higher in
newborns. Most commonly
used opioid for short, painful
procedures, but transdermal
route is more effective in
chronic pain situations.
Hydromorphone IV/SQ: 0.015 5–10 3–4 Less sedation, nausea, and
PO: 0.02–0.1 30–60 pruritus than morphine.
Methadone IV: 0.1 5–10 4–24 Initial dose may produce
PO: 0.1 30–60 4–24 analgesia for 3–4 hr; duration
of action is increased with
repeated dosing.
Morphine IV: 0.1 5–10 3–4 • Seizures in neonates The gold standard against
IM/SQ: 0.1–0.2 10–30 4–5 • Can cause significant which all other opioids are
PO: 0.3–0.5 30–60 4–5 histamine release compared. Available in
sustained-release form for
chronic pain.
Oxycodone PO: 0.1 30–60 3–4 Available in sustained-release
form for chronic pain. Much
less nauseating than codeine.
Benzodiazepines Short Midazolam IV 1–3 1–2 • Has rapid and predictable onset
of action, short recovery time
IM/IN 5–10 • Causes amnesia
PO/PR 10–30 • Results in mild depression of
hypoxic ventilatory drive
Intermediate Diazepam IV (painful) 1–3 0.25–1 • Poor choice for procedural
sedation
PR 7–15 2–3 • Excellent for muscle relaxation or
prolonged sedation
PO 30–60 2–3 • Painful on IV injection
• Faster onset than midazolam
Long Lorazepam IV 1–5 3–4 • Poor choice for procedural
sedation
IM 10–20 3–6 • Ideal for prolonged anxiolysis,
PO 30–60 3–6 seizure treatment
maintain hydration and does not suffer known adverse Sedation Assessment
effects of sedation such as nausea or vomiting. Recovery Whenever sedation is administered, substantial patient
time after sedation protocols varies but typically ranges from morbidity and mortality is a possibility. Optimal sedation
60 to 120 minutes. Any decision for admission to the management requires assessing a child’s level of sedation
hospital should be made on a multidisciplinary level with at regular intervals to guide the clinician in titration of sub-
the team performing the procedure and based on the child’s sequent therapy to avoid over- or undersedation. The most
medical history and risk for postprocedure complications. commonly used sedation assessment tools are the State
For example, a child who receives 10 minutes of sedation Behavioral Scale (SBS) and the COMFORT Scale. Both the
for incision and drainage of an abscess on the thigh may be SBS and COMFORT Scale have been validated in critically
able to go home after an appropriate period of observation, ill children. (8)(9) The SBS defines the sedation-agitation
but a child who has reduction of a supracondylar fracture continuum to guide goal-directed therapy using a patient’s
in the emergency department may need to be admitted for response to voice, gentle touch, and noxious stimuli such as
ongoing pain management and determination of surgical suctioning. The COMFORT Scale measures 5 behavioral
disposition. variables (alertness, facial tension, muscle tone, agitation,
and movement) and 3 physiologic variables (heart rate, re-
SEDATION IN THE PEDIATRIC INTENSIVE CARE UNIT spiration, and blood pressure). These tools provide a con-
sistent but modifiable goal for PICU clinicians to titrate
Sedation is not limited to children undergoing procedures; sedation to the level necessary for each individual child.
another important area in which sedation is used is for the Sedatives can be increased or decreased by the nurses or
mechanically ventilated child in the PICU. The ideal seda- physicians based on the goal sedation score, as shown in the
tion management plan for any patient who is mechanically recently published RESTORE trial. (10)
ventilated encompasses analgesia to treat pain from the
noxious stimuli of the endotracheal tube and sedation to Sedatives and Analgesics
provide adequate comfort and safety as required for the Most recommendations regarding sedation management
child’s critical illness, while optimizing patient-ventilator in the pediatric intensive care population are based on expe-
synchrony and minimizing the risk of delirium and sleep rience and best practice rather than evidence-based medicine.
disturbances. (7) For the purposes of this review, we focus on Very few studies have evaluated the pharmacokinetic and
sedation of the critically ill child in the PICU. Given the pharmacodynamic properties of analgesic and sedative drugs
unique physiology, environment, and pharmacologic man- in critically ill patients.
agement of neonates, sedation in the neonatal intensive care Sedation and analgesia in the PICU is often needed for
unit is beyond the scope of this review. prolonged periods of time, and optimal agents for long-term
Ketamine (1 mg/kg/dose IV 1–3 doses) Lowest rates of adverse events when ketamine used alone‡
Ketamine þ midazolam þ atropine (“ketazolam”) Atropine ¼ antisialogogue
IV route: Midazolam ¼ counter emergence delirium
• Ketamine 1 mg/kg/dose 1–3 doses
• Midazolam 0.05 mg/kg 1 dose
• Atropine 0.02 mg/kg 1 dose
IM route: combine (use smallest volume possible)
• Ketamine 1.5–2 mg/kg
• Midazolam 0.15–0.2 mg/kg
• Atropine 0.02 mg/kg
• Midazolam þ fentanyl High likelihood of respiratory depression
Midazolam 0.1 mg/kg IV 3 doses PRN
Fentanyl 1 mg/kg IV 3 doses PRN Infuse fentanyl no more frequently than every 3 min
sedation differ from those used for procedural sedation. Benzodiazepines are potent amnestics, hypnotics, and
For example, propofol infusions are rarely prescribed for skeletal muscle relaxants. However, most sedatives, specif-
longer than 4 hours in critically ill children requiring ically benzodiazepines, chloral hydrate, and the barbiturates,
sedation due to a concern for the development of propofol have no analgesic properties. Benzodiazepines are also inde-
infusion syndrome, which is characterized by cardiac pendent risk factors for development of delirium.
failure, rhabdomyolysis, metabolic acidosis, renal failure, a-Agonists such as clonidine and dexmedetomidine are
and death. The most commonly used agents for long-term useful adjuvants because they cause very little respiratory
sedation in the PICU are benzodiazepines, opioids, and depression and are not deleterious to natural sleep when
a-agonists. (7) compared to opioids and benzodiazepines.
Opioids commonly used in pain management are m-opioid
receptor agonists. All of the m-opioid receptor agonists have Neuromuscular Blockade
similar pharmacodynamic effects at equianalgesic doses In clinical scenarios in which sedation and analgesia are
(the equivalent dose of analgesic required to achieve the adequate, immobility may be necessary to facilitate recovery
same amount of analgesia). These pharmacodynamic from the child’s illness. Therefore, in rare instances, long-
effects include analgesia, respiratory depression, sedation, term neuromuscular blockade (NMB) may be used. NMB
nausea and vomiting, pruritus, constipation, miosis, toler- has no analgesic or sedating qualities, and the level of NMB
ance, and physical dependence. Fentanyl is the most must be constantly monitored to prevent prolonged block-
commonly used analgesic for procedures and pain con- ade. Commonly used NMB agents in the PICU include
trol in the PICU. (7) Ironically, fentanyl has the least rocuronium, vecuronium, and cisatracurium. Cisatracu-
sedating quality of all of the opioids, but it is short-acting rium is commonly used as a continuous infusion in chil-
following single doses. Of note, fentanyl can be long- dren requiring long-term NMB and is the preferred agent
acting following infusions due to its “context-sensitive for children with renal dysfunction due to an organ-
half-life” or the time needed for blood plasma concen- independent metabolic pathway called “Hofmann elimi-
trations of a drug to decline by one-half after discontinu- nation.” Clearance of drugs through Hofmann elimination
ing the infusion once the infusion achieves a constant is best described as spontaneous nonenzymatic degrada-
plasma concentration. tion at normal pH and body temperature.
Sedative-Hypnotic
Diazepam PO 0.25–0.3 mg/kg
IV (painful) 0.1 mg/kg; maximum 0.6 mg/kg within 8 hours
Dexmedetomidine IN 1–2 mg/kg
IV 0.5–2 mg/kg over 10 min, followed by 0.2–1 mg/kg/hr
Diphenhydramine PO, IV, IM 1 mg/kg; maximum 50 mg/dose
Hydroxyzine PO 2 mg/kg/day divided every 6–8 hr; maximum 600 mg/24 hr
IM 0.5–1 mg/kg/dose every 4–6 hr; maximum 600 mg/24 hr
Lorazepam PO, IV, IM 0.05 mg/kg; maximum 2 mg/dose
Midazolam PO 0.5–0.8 mg/kg; maximum 20 mg/dose
PR 0.5–1 mg/kg
IN 0.2–0.3 mg/kg
IM 0.15–0.2 mg/kg
IV sedation 0.1 mg/kg; maximum 10 mg/total dose
Analgesic
Acetaminophen PO, PR, IV 10–15 mg/kg every 4–6 hr (if >50 kg, 650–1000 mg every 4–6 hr)
Fentanyl IV 1 mg/kg
IV infusion 1–5 mg/kg/hr
PO oralet 10–15 mg/kg; maximum 400 mg
IN 1 mg/kg
Hydrocodone* PO 0.135 mg/kg every 4–6 hr; maximum 2 mg/dose
Hydromorphone IV 0.015 mg/kg; maximum 2 mg/dose
IV infusion 2–4 mg/kg/hr
Ketorolac IV, IM 0.5 mg/kg every 6 hr; maximum 30 mg/dose
Methadone PO, IV, IM, SQ 0.1 mg/kg every 8–12 hr; maximum 10 mg/dose
Morphine IV 0.05–0.2 mg/kg; maximum 15 mg/dose
IV infusion 10–40 mg/kg/hr
Oxycodone PO 0.1 mg/kg every 4–6 hr; maximum 5 mg/dose
Other
Ketamine PO 5 mg/kg
IV 0.25–2 mg/kg
IM 2–5 mg/kg
Weaning of Sedatives/Analgesics The length of exposure should correlate with the weaning
Tolerance and physical dependence are unavoidable conse- strategy. (11)
quences of prolonged use and high quantities of opioids and Weaning sedatives and analgesics requires thoughtful
sedatives administered to the critically ill patient. Tolerance planning. To simplify the weaning process, clinicians should
develops following opioid and benzodiazepine use to some make every effort to convert the patient from intravenous
degree following 3 to 5 days of usage. At this point, the risk to oral therapy and from continuous infusions to inter-
for withdrawal symptoms is increased, and patients should mittent bolus therapy. This substantially eases patient care
be weaned at the appropriate time from their opioids and can allow for final tapering and weaning in an out-
and sedatives rather than abruptly discontinuing therapy. patient setting. Changing from one opioid to another may
1. You use a combination of fentanyl and midazolam to provide procedural sedation to a REQUIREMENTS: Learners
child undergoing reduction of a fractured radius in your emergency department. After the can take Pediatrics in
medications are infused intravenously, the child cannot be easily aroused but does cry out Review quizzes and claim
softly and withdraw his arm on the initial attempts at reduction. Of the following, which credit online only at:
best describes the level of procedural sedation that has been achieved for this child? http://pedsinreview.org.
A. Conscious sedation.
B. Deep sedation. To successfully complete
C. General anesthesia. 2016 Pediatrics in Review
D. Mild sedation. articles for AMA PRA
E. Moderate sedation. Category 1 CreditTM,
2. Which of the following statements is true regarding complications during procedural learners must
sedation? demonstrate a minimum
A. Most complications are due to frequent measurement of end-tidal carbon dioxide performance level of 60%
levels. or higher on this
B. Complications most often occur 5 to 10 minutes after administration of intravenous assessment, which
medications. measures achievement of
C. Complications rarely occur after the procedure is completed. the educational purpose
D. Most complications are due to cardiovascular effects of the medications used. and/or objectives of this
E. Complications most often occur within the first minute of sedation. activity. If you score less
than 60% on the
3. A 4-year-old critically ill child is intubated and under heavy sedation in the pediatric
assessment, you will be
intensive care unit. Which of the following tools is most helpful in avoiding either over- or
given additional
undersedation?
opportunities to answer
A. American Society of Anesthesiology Scale. questions until an overall
B. Glasgow Coma Scale. 60% or greater score is
C. Mallampati Score. achieved.
D. State Behavioral Scale.
E. Trauma Score.
This journal-based CME
4. A 6-year-old child requires prolonged sedation in the pediatric intensive care unit after
activity is available
multisystem trauma. The surgeon estimates that the child will require this sedation for at
through Dec. 31, 2018,
least 3 to 4 days. Prolonged use of which of the following medications is most likely to lead
however, credit will be
to the development of delirium in this child?
recorded in the year in
A. Clonidine. which the learner
B. Dexmedetomidine. completes the quiz.
C. Midazolam.
D. Morphine.
E. Propofol.
5. A patient in the emergency department is in need of procedural sedation for complex
laceration repair. The child has a history of asthma and is actively wheezing. After 3
albuterol treatments and a dose of systemic corticosteroids, the wheezing is much
improved but still present. According to the 5-point Physical Status Classification System of
the American Society of Anesthesiologists (ASA), what is the ASA class for this patient?
A. Class I.
B. Class II.
C. Class III.
D. Class IV.
E. Class V.
Updated Information & including high resolution figures, can be found at:
Services http://pedsinreview.aappublications.org/content/37/5/203
References This article cites 19 articles, 3 of which you can access for free at:
http://pedsinreview.aappublications.org/content/37/5/203#BIBL
Subspecialty Collections This article, along with others on similar topics, appears in the
following collection(s):
Medical Education
http://beta.pedsinreview.aappublications.org/cgi/collection/medical_
education_sub
Journal CME
http://beta.pedsinreview.aappublications.org/cgi/collection/journal_c
me
Anesthesiology/Pain Medicine
http://beta.pedsinreview.aappublications.org/cgi/collection/anesthesi
ology:pain_medicine_sub
Permissions & Licensing Information about reproducing this article in parts (figures, tables) or
in its entirety can be found online at:
http://beta.pedsinreview.aappublications.org/site/misc/Permissions.x
html
Reprints Information about ordering reprints can be found online:
http://beta.pedsinreview.aappublications.org/site/misc/reprints.xhtml
The online version of this article, along with updated information and services, is
located on the World Wide Web at:
http://pedsinreview.aappublications.org/content/37/5/203
Pediatrics in Review is the official journal of the American Academy of Pediatrics. A monthly
publication, it has been published continuously since 1979. Pediatrics in Review is owned,
published, and trademarked by the American Academy of Pediatrics, 141 Northwest Point
Boulevard, Elk Grove Village, Illinois, 60007. Copyright © 2016 by the American Academy of
Pediatrics. All rights reserved. Print ISSN: 0191-9601.